Brian D. King

Member since:  May 10, 2017

Chief Executive Officer, MedPlast, Inc.,
Duxbury, Massachusetts, U.S.A

Mr. King is the president and chief executive officer, and a director, of MedPlast, Inc., a private global services provider to the medical device industry, effective on May 1, 2017.  From June 2015 to March 2017, Brian King served as an Operating Advisor for Thomas H Lee Partners.  From June 2014 to June 2015, Mr. King served as Chief Transformation Officer and Chief Operating Officer at DePuy Synthes, a Johnson & Johnson company, which designs and manufactures orthopedic and neurological devices and supplies. From 2004 to 2014, Mr. King served in various executive positions at Covidien, formerly Tyco Healthcare, a global healthcare products company and manufacturer of medical devices and supplies, which was later acquired by Medtronic. At Covidien, Mr. King served as Group President, Emerging Markets (2010-2014), President, Covidien Asia (2008-2010), Senior Vice President, Global Operations and Quality (2005-2008), and Vice President, Operational Excellence (2004-2005). Mr. King holds an MBA from Harvard Business School, Master of Science from the Pennsylvania State University, and Bachelor of Science from the United States Naval Academy.  Mr. King currently serves on the board of directors of PCI Pharma Services, a privately held entity, and previously served on the board of directors of Houston Street Exchange, Inc. and B&C Research Corporation, both privately held entities.

Business Wire InvestorHQsm